Article Details

Inflammatix Named a Finalist for AACC's Disruptive Technology Award For Its Rapid HostDx™ Tests

Retrieved on: 2019-05-16 02:22:30

Tags for this article:

Click the tags to see associated articles and topics

Inflammatix Named a Finalist for AACC's Disruptive Technology Award For Its Rapid HostDx™ Tests. View article details on hiswai:

Excerpt

<div>based company is funded by <b>Khosla Ventures</b>, Northpond Ventures, the Stanford-StartX Fund and Think.Health Ventures. For more information ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo